- Home
- STAA vs CIM Comparison
STAA vs CIM Comparison
Compare STAA & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAA
- CIM
- Stock Information
- Founded
- STAA 1982
- CIM 2007
- Country
- STAA United States
- CIM United States
- Employees
- STAA N/A
- CIM N/A
- Industry
- STAA Ophthalmic Goods
- CIM Real Estate Investment Trusts
- Sector
- STAA Health Care
- CIM Real Estate
- Exchange
- STAA Nasdaq
- CIM Nasdaq
- Market Cap
- STAA 1.4B
- CIM 1.1B
- IPO Year
- STAA N/A
- CIM 2007
- Fundamental
- Price
- STAA $26.50
- CIM $13.06
- Analyst Decision
- STAA Hold
- CIM Buy
- Analyst Count
- STAA 8
- CIM 3
- Target Price
- STAA $22.50
- CIM $15.50
- AVG Volume (30 Days)
- STAA 815.1K
- CIM 683.7K
- Earning Date
- STAA 10-29-2025
- CIM 11-05-2025
- Dividend Yield
- STAA N/A
- CIM 11.36%
- EPS Growth
- STAA N/A
- CIM N/A
- EPS
- STAA N/A
- CIM 1.28
- Revenue
- STAA $224,449,000.00
- CIM $312,281,000.00
- Revenue This Year
- STAA N/A
- CIM $15.99
- Revenue Next Year
- STAA $27.24
- CIM $9.70
- P/E Ratio
- STAA N/A
- CIM $10.14
- Revenue Growth
- STAA N/A
- CIM 1.91
- 52 Week Low
- STAA $13.50
- CIM $9.85
- 52 Week High
- STAA $35.39
- CIM $16.27
- Technical
- Relative Strength Index (RSI)
- STAA 46.84
- CIM 32.06
- Support Level
- STAA $26.10
- CIM $12.95
- Resistance Level
- STAA $27.49
- CIM $13.57
- Average True Range (ATR)
- STAA 0.41
- CIM 0.22
- MACD
- STAA -0.15
- CIM -0.08
- Stochastic Oscillator
- STAA 35.97
- CIM 8.63
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.